Malassezia species and scalp stratum corneum

Malassezia species, primarily M. globosa and M. restricta, are lipophilic yeasts that constitute a major part of the scalp's microbiome and are the primary etiological agents in dandruff and seborrheic dermatitis (Dawson, 2007, Journal of Investigative Dermatology Symposium Proceedings). These yeasts produce extracellular lipases that degrade sebum into irritating free fatty acids, such as oleic acid, which penetrate the scalp stratum corneum and induce inflammation (DeAngelis et al., 2005, Journal of Investigative Dermatology Symposium Proceedings). The resulting damage to the stratum corneum barrier leads to increased transepidermal water loss and abnormal keratinocyte turnover, manifesting as visible flaking (Gemmer et al., 2002, Journal of Clinical Microbiology). Pharmacological management involves the use of antifungal agents like ketoconazole and zinc pyrithione to suppress Malassezia populations, alongside keratolytic agents that help restore the integrity of the stratum corneum (Gupta et al., 2004, American Journal of Clinical Dermatology). This target complex is unique as it involves both a microbial pathogen and the host's physical barrier, requiring a multifaceted therapeutic approach (StatPearls, 2023, Seborrheic Dermatitis). Safety concerns for treatments targeting this interface include localized skin irritation and the potential for disrupting the broader skin microbiome (PubMed, 2019, Frontiers in Cellular and Infection Microbiology). Monitoring efficacy often involves measuring yeast density or inflammatory biomarkers like the IL-1ra/IL-18 ratio in the stratum corneum (Journal of Dermatological Science, 2015).

Other names

Malassezia-host interfaceScalp stratum corneum-Malassezia complexPityrosporumScalp microbiome-barrier interface

Antifungal agents inhibit Malassezia growth by disrupting ergosterol synthesis or cell membrane integrity, while keratolytic agents promote the desquamation of the stratum corneum to remove yeast habitats and scales.